- Report
- December 2022
- 78 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- October 2022
- 194 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- January 2024
- 213 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- April 2023
- 206 Pages
Global
From €3340EUR$3,500USD£2,799GBP
€6681EUR$7,000USD£5,597GBP
- Report
- June 2023
- 317 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- February 2024
- 379 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- September 2023
- 324 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- January 2023
- 356 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- August 2023
- 336 Pages
Global
From €2625EUR$2,750USD£2,199GBP
€5249EUR$5,500USD£4,398GBP
- Report
- December 2021
- 286 Pages
Global
From €2505EUR$2,625USD£2,099GBP
€5010EUR$5,250USD£4,198GBP
- Report
- March 2022
- 208 Pages
United States
From €3340EUR$3,500USD£2,799GBP
- Report
- January 2024
- 260 Pages
Global
From €2338EUR$2,450USD£1,959GBP
- Report
- July 2023
- 273 Pages
Global
From €2625EUR$2,750USD£2,199GBP
€5249EUR$5,500USD£4,398GBP
- Report
- June 2023
- 361 Pages
Global
From €2625EUR$2,750USD£2,199GBP
€5249EUR$5,500USD£4,398GBP
- Report
- August 2023
- 141 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- February 2022
- 312 Pages
Global
From €2863EUR$3,000USD£2,399GBP
- Report
- March 2024
- 128 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- February 2024
- 442 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- July 2023
- 138 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- October 2019
Global
From €2672EUR$2,800USD£2,239GBP

The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases.
Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field.
The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more